Anticoagulation

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22: P2Y12i Vs Aspirin Monotherapy in CAD Pts

Marco Valgimigli,

Watch time: 4:59
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli

Marco Valgimigli,

Watch time: 4:13

Watch time: 3:52:31
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients

Harald Thune Jorstad,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

Stuart J Head , Ad JJC Bogers , A Pieter Kappetein ,

Giulia Magnani , Marco Valgimigli ,

Michael Haude ,

Darshni Arishta Jhagroe , Jur ten Berg ,

Sri Raveen Kandan , Thomas W Johnson ,

Eunice NC Onwordi , Amr Gamal , Azfar Zaman ,

William R Colyer Jr , Christopher J Cooper ,

Michael Tsang , Sanjit Jolly ,

Anticoagulation after PCI in Atrial Fibrillation

Christopher P Cannon, Georg Nickenig,

Justin E Davies,

ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall,

Jean-Philippe Collet ,

Media

Watch time: 3:52:31
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

AHA 2019: Clinical Data Update on TWILIGHT and TWILIGHT-ACS

Marc P Bonaca, Roxana Mehran,

Media

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22: P2Y12i Vs Aspirin Monotherapy in CAD Pts

Marco Valgimigli,

Watch time: 4:59
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli

Marco Valgimigli,

Watch time: 4:13

Watch time: 3:52:31

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3:61:38 (47 videos)
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

George D Dangas, Adrian P Banning, Davide Cao, et al

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients

Harald Thune Jorstad,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

EuroPCR 2021: Findings From the POEM Study

Giulio G Stefanini,

ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall,

Tarv Dhanjal, Isabel Deisenhofer, John D Day, et al

John Eikelboom, Ken Okumura, Jan Steffel, et al

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

TCT Connect 2020: The XIENCE 90/28 Trials

Roxana Mehran,

Jens Erik Nielsen-Kudsk, A John Camm, Vivek Reddy, et al

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter – What's hot at ACC 2020

Nicolas M Van Mieghem, Joost Daemen,

CRT 2020: Duration of DAPT treatment in ST prevention

Dean J Kereiakes,

JIM 2020: Onyx ONE study

Gennaro Sardella,

BCIS ACI 2020: Update on DAPT

Robert F Storey,

AHA 2019: Updates from GALILEO-4D

Ole De Backer,

Articles

Device-Related Thrombus After Left Atrial Appendage Closure

Philippe Garot

,

Bertrand Cormier

,

Jérôme Horvilleur

,

Published:

25 February 2019

Citation:

Interventional Cardiology Review 2019;14(1):42–4

DOI:

https://doi.org/10.15420/icr.2018.21.3
  • Views: Views 514
  • Downloads: Downloads 2
  • Citations: 7

Anticoagulant Therapy for Acute Coronary Syndromes

Eunice NC Onwordi

,

Amr Gamal

,

Azfar Zaman

,

Citation:

Interventional Cardiology Review 2018;13(2):87–92.

DOI:

https://doi.org/10.15420/icr.2017:26:1
  • Views: Views 2594
  • Downloads: Downloads 18
  • Citations: 4

NOACs After ACS: Is There a Role?

Paul Guedeney

,

Birgit Vogel

,

Roxana Mehran

,

Citation:

Interventional Cardiology Review 2018;13(2):93–8.

DOI:

https://doi.org/10.15420/icr.2018:5:2
  • Views: Views 982
  • Downloads: Downloads 8
  • Citations: 4

Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

Giulia Magnani

,

Marco Valgimigli

,

Citation:

Interventional Cardiology Review 2016;11(1):51–3

DOI:

http://dx.doi.org/10.15420/icr.2015:17:2
  • Views: Views 6339
  • Downloads: Downloads 4